BBIO Insider Trading

Insider Ownership Percentage: 28.52%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $62,881,159.96

BridgeBio Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at BridgeBio Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BridgeBio Pharma Share Price & Price History

Current Price: $30.90
Price Change: Price Increase of +0.04 (0.13%)
As of 03/28/2024 10:57 AM ET

This chart shows the closing price history over time for BBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BridgeBio Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2024Randal W. ScottDirectorSell2,500$34.00$85,000.006,500View SEC Filing Icon  
1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.551,764View SEC Filing Icon  
12/26/2023Frank McCormickDirectorSell100,000$42.06$4,206,000.00627,689View SEC Filing Icon  
12/18/2023Randal W. ScottDirectorSell2,000$40.00$80,000.009,000View SEC Filing Icon  
8/17/2023Brian C. StephensonCFOSell22,683$28.59$648,506.9736,710View SEC Filing Icon  
8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.684,813,197View SEC Filing Icon  
7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.0025,120,991View SEC Filing Icon  
5/17/2023Brian C. StephensonCFOSell24,424$14.01$342,180.2436,408View SEC Filing Icon  
5/17/2023Neil KumarCEOSell51,552$14.01$722,243.524,813,197View SEC Filing Icon  
4/5/2023Brian C. StephensonCFOSell55,500$15.45$857,475.00101,337View SEC Filing Icon  
4/5/2023Neil KumarCEOSell120,000$15.46$1,855,200.001,132,722View SEC Filing Icon  
3/3/2023Brian C. StephensonCFOSell62,692$10.96$687,104.32156,837View SEC Filing Icon  
3/3/2023Neil KumarCEOSell120,000$10.96$1,315,200.001,252,722View SEC Filing Icon  
2/17/2023Brian C. StephensonCFOSell17,717$12.70$225,005.90219,529View SEC Filing Icon  
2/17/2023Neil KumarCEOSell44,798$12.70$568,934.604,813,197View SEC Filing Icon  
2/3/2023Brian C. StephensonCFOSell61,040$11.01$672,050.40219,184View SEC Filing Icon  
2/3/2023Neil KumarCEOSell120,000$11.01$1,321,200.001,372,722View SEC Filing Icon  
1/5/2023Brian C. StephensonCFOSell61,040$7.67$468,176.80280,224View SEC Filing Icon  
1/5/2023Neil KumarCEOSell120,000$7.67$920,400.001,492,722View SEC Filing Icon  
11/17/2022Brian C. StephensonCFOSell19,678$9.40$184,973.20341,264View SEC Filing Icon  
11/17/2022Neil KumarCEOSell34,640$9.40$325,616.004,813,197View SEC Filing Icon  
3/14/2022Douglas A. DachilleDirectorBuy10,000$8.19$81,900.00View SEC Filing Icon  
1/4/2022Douglas A. DachilleDirectorBuy5,000$16.82$84,100.00View SEC Filing Icon  
12/30/2021Ronald J. DanielsDirectorBuy10,402$14.34$149,164.68View SEC Filing Icon  
12/28/2021Ronald J. DanielsDirectorBuy11,745$12.73$149,513.85View SEC Filing Icon  
8/4/2021Richard H. SchellerInsiderSell13,777$53.23$733,349.71View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BridgeBio Pharma (NASDAQ:BBIO)

99.85% of BridgeBio Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BridgeBio Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/27/2024Nomura Holdings Inc.257,995$10.42M0.0%+9.8%0.147%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.12,800,294$516.75M0.0%+13.5%7.280%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP1,495,114$60.36M0.0%+5.3%0.850%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC6,073$0.25M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/20/2024Quarry LP1,250$50K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD658,362$26.58M0.0%+962.3%0.378%Search for SEC Filing on Google Icon
2/15/2024Exome Asset Management LLC65,113$2.63M2.6%N/A0.037%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC9,084$0.37M0.2%-49.6%0.005%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc96,965$3.91M0.0%+4.6%0.056%Search for SEC Filing on Google Icon
2/15/2024Sphera Funds Management LTD.282,146$11.39M1.8%-18.3%0.162%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.12,800,294$516.75M0.0%+13.5%7.358%Search for SEC Filing on Google Icon
2/15/2024Voloridge Investment Management LLC1,105,989$44.65M0.2%-11.5%0.636%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC187,021$7.55M0.0%+147.2%0.108%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC46,067$1.86M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC317,647$12.82M0.0%-42.1%0.183%Search for SEC Filing on Google Icon
2/15/2024Occudo Quantitative Strategies LP9,510$0.38M0.1%N/A0.005%Search for SEC Filing on Google Icon
2/15/2024Osterweis Capital Management Inc.88,485$3.57M0.2%N/A0.051%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP706,800$28.53M4.6%-27.3%0.406%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD658,362$26.58M0.0%+962.3%0.378%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC46,347$1.87M0.1%-14.0%0.027%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC100,734$4.07M0.6%+0.7%0.058%Search for SEC Filing on Google Icon
2/15/2024Garden State Investment Advisory Services LLC11,828$0.48M0.2%N/A0.007%Search for SEC Filing on Google Icon
2/15/2024Gotham Asset Management LLC8,486$0.34M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/15/2024Granahan Investment Management LLC388,302$15.68M0.5%+256.8%0.223%Search for SEC Filing on Google Icon
2/15/2024Healthcare of Ontario Pension Plan Trust Fund289,000$11.67M0.0%+5,680.0%0.164%Search for SEC Filing on Google Icon
2/15/2024Boone Capital Management LLC440,845$17.80M4.2%+40.7%0.253%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC185,137$7.47M2.7%N/A0.106%Search for SEC Filing on Google Icon
2/14/2024Hhlr Advisors LTD.1,391,240$56.16M1.1%-50.0%0.800%Search for SEC Filing on Google Icon
2/14/2024Altitude Crest Partners Inc.754,560$30.46M20.4%N/A0.434%Search for SEC Filing on Google Icon
2/14/2024Creative Planning5,033$0.20M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/14/2024Superstring Capital Management LP206,326$8.33M5.9%N/A0.119%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG33,300$1.34M0.0%-57.7%0.019%Search for SEC Filing on Google Icon
2/14/2024Nomura Holdings Inc.257,995$10.42M0.0%+9.8%0.148%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.12,955$0.52M0.2%-92.8%0.007%Search for SEC Filing on Google Icon
2/13/2024Envestnet Asset Management Inc.36,359$1.47M0.0%+24.3%0.021%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp1,154,972$46.63M0.0%+0.1%0.664%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado10,191$0.41M0.0%-41.4%0.006%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 8,217$0.33M0.0%+313.7%0.005%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP181,697$7.34M0.0%+49.0%0.104%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC276,073$11.15M0.0%-11.9%0.159%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC18,301$0.74M0.1%N/A0.011%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 744,132$30.04M0.0%+11.8%0.428%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC23,071$0.93M0.1%+50.8%0.013%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System98,443$3.97M0.0%-4.7%0.057%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.219,099$8.85M0.0%N/A0.126%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc29,074$1.17M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/9/2024Primecap Management Co. CA944,000$38.11M0.0%+0.6%0.543%Search for SEC Filing on Google Icon
2/9/2024Orion Portfolio Solutions LLC6,192$0.24M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/9/2024Commerce Bank6,043$0.24M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE15,656$0.63M0.0%-24.5%0.009%Search for SEC Filing on Google Icon
2/9/2024Assetmark Inc.2,931$0.12M0.0%+46.8%0.002%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG985,510$39.79M0.0%+545.9%0.566%Search for SEC Filing on Google Icon
2/9/2024Norges Bank1,160,342$46.84M0.0%N/A0.667%Search for SEC Filing on Google Icon
2/8/2024Mizuho Markets Americas LLC64,379$2.60M0.1%-20.1%0.037%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.192,842$7.79M0.0%+9.2%0.111%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC7,429$0.30M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.6,113$0.23M0.0%-60.0%0.004%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.943,484$38.09M0.0%+26.5%0.542%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP47,629$1.92M0.0%+4.9%0.027%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets127,260$5.14M0.0%-14.5%0.073%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas20,632$0.83M0.0%-17.7%0.012%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.14,769$0.60M0.0%-8.2%0.008%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,123,220$45.34M0.0%+6.3%0.646%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank14,428$0.58M0.0%-8.5%0.008%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC9,436$0.38M0.0%-37.9%0.005%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank176,100$7.11M0.0%-9.3%0.101%Search for SEC Filing on Google Icon
2/6/2024New York Life Investment Management LLC20,990$0.85M0.0%-2.1%0.012%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.459,569$18.55M0.0%+5.5%0.264%Search for SEC Filing on Google Icon
2/5/2024Certuity LLC6,400$0.26M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/5/2024Sargent Investment Group LLC5,276$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/2/2024State of New Jersey Common Pension Fund D86,772$3.50M0.0%+5.6%0.050%Search for SEC Filing on Google Icon
2/2/2024Atria Wealth Solutions Inc.5,313$0.21M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/1/2024Jennison Associates LLC19,357$0.78M0.0%-4.7%0.011%Search for SEC Filing on Google Icon
2/1/2024Duality Advisers LP80,192$3.24M0.3%+63.1%0.046%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB26,350$1.06M0.0%+6.5%0.015%Search for SEC Filing on Google Icon
1/31/2024abrdn plc284,993$11.51M0.0%N/A0.164%Search for SEC Filing on Google Icon
1/31/2024Xponance Inc.6,962$0.28M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.447,171$18.05M0.0%-4.0%0.257%Search for SEC Filing on Google Icon
1/30/2024HealthInvest Partners AB23,985$0.97M0.8%N/A0.014%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 20,630$0.83M0.0%+17.9%0.012%Search for SEC Filing on Google Icon
1/30/2024Mackenzie Financial Corp6,992$0.28M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio9,000$0.36M0.0%+30.4%0.005%Search for SEC Filing on Google Icon
1/30/2024Vontobel Holding Ltd.30,811$1.24M0.0%-53.6%0.018%Search for SEC Filing on Google Icon
1/29/2024WCM Investment Management LLC291,643$12.19M0.0%+2.5%0.168%Search for SEC Filing on Google Icon
1/26/2024Moody Aldrich Partners LLC124,984$5.05M0.9%-9.1%0.072%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC4,183$0.17M0.0%-71.3%0.002%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC40,220$1.62M0.0%-7.4%0.023%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.65,773$2.66M0.0%+1.4%0.038%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.20,120$0.81M0.2%+382.4%0.012%Search for SEC Filing on Google Icon
1/17/2024Assenagon Asset Management S.A.36,734$1.48M0.0%-9.9%0.021%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates9,073$0.37M0.0%N/A0.005%Search for SEC Filing on Google Icon
1/11/2024Ziegler Capital Management LLC27,994$1.13M0.1%-1.7%0.016%Search for SEC Filing on Google Icon
1/11/2024Handelsinvest Investeringsforvaltning7,423$0.30M0.1%N/A0.004%Search for SEC Filing on Google Icon
1/8/2024Diversified Trust Co17,636$0.71M0.0%+3.1%0.010%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.11,275,981$297.35M0.0%-3.5%6.482%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP1,419,550$37.43M0.0%N/A0.816%Search for SEC Filing on Google Icon
11/30/2023American Century Companies Inc.308,292$8.13M0.0%+2,671.2%0.177%Search for SEC Filing on Google Icon
11/17/2023Diversified Trust Co17,111$0.45M0.0%+2.5%0.010%Search for SEC Filing on Google Icon
11/16/2023Ironwood Investment Management LLC64,537$1.70M1.0%-2.8%0.037%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al81,150$2.14M0.0%N/A0.047%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BridgeBio Pharma logo
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.
Read More on BridgeBio Pharma

Today's Range

Now: $30.90
Low: $30.76
High: $31.22

50 Day Range

MA: $33.26
Low: $27.35
High: $39.23

52 Week Range

Now: $30.90
Low: $12.75
High: $44.32

Volume

116,929 shs

Average Volume

1,785,964 shs

Market Capitalization

$5.43 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of BridgeBio Pharma?

BridgeBio Pharma's top insider investors include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. Neil Kumar (CEO)
  3. Frank Mccormick (Director)
  4. Brian C Stephenson (CFO)
  5. Randal W Scott (Director)
  6. Hannah Valantine (Director)
Learn More about top insider investors at BridgeBio Pharma.

Who are the major institutional investors of BridgeBio Pharma?

BridgeBio Pharma's top institutional investors include:
  1. Vanguard Group Inc. — 7.36%
  2. Vanguard Group Inc. — 7.28%
  3. Wellington Management Group LLP — 0.85%
  4. Hhlr Advisors LTD. — 0.80%
  5. Norges Bank — 0.67%
  6. Northern Trust Corp — 0.66%
Learn More about top institutional investors of BridgeBio Pharma stock.

Which institutional investors are selling BridgeBio Pharma stock?

Within the previous quarter, BBIO stock was sold by these institutional investors:
  1. Hhlr Advisors LTD.
  2. Octagon Capital Advisors LP
  3. Nuveen Asset Management LLC
  4. Sectoral Asset Management Inc.
  5. Voloridge Investment Management LLC
  6. Portman Square Capital LLP
  7. Sphera Funds Management LTD.
  8. Citadel Advisors LLC
Within the previous year, company insiders that have sold BridgeBio Pharma company stock include:
  1. Global Investors Lp Viking (Major Shareholder)
  2. Neil Kumar (CEO)
  3. Frank Mccormick (Director)
  4. Brian C Stephenson (CFO)
  5. Randal W Scott (Director)
  6. Hannah Valantine (Director)
Learn More investors selling BridgeBio Pharma stock.

Which institutional investors are buying BridgeBio Pharma stock?

During the last quarter, BBIO stock was purchased by institutional investors including:
  1. Vanguard Group Inc.
  2. Vanguard Group Inc.
  3. Norges Bank
  4. UBS Group AG
  5. Altitude Crest Partners Inc.
  6. Price T Rowe Associates Inc. MD
  7. Price T Rowe Associates Inc. MD
  8. abrdn plc